Xbrane Biopharma AB's market cap is currently €667.51M. The company's EPS TTM is kr0.11; its P/E ratio is 5.05; Xbrane Biopharma AB is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is kr0.01. See an overview of income statement, balance sheet, and cash flow financials.
